Home/Filings/4/0001790340-26-000012
4//SEC Filing

Hall Brett Matthew 4

Accession 0001790340-26-000012

CIK 0001790340other

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 4:07 PM ET

Size

5.0 KB

Accession

0001790340-26-000012

Insider Transaction Report

Form 4
Period: 2026-01-15
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Purchase

    Class A Common Stock

    [F1]
    2026-01-15$4.57/sh+2,298$10,502376,496 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.57 to $4.571. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Brett Matthew Hall|2026-01-16

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1
  • filerCIK 0001870437

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:07 PM ET
Size
5.0 KB